We’re glad to see you’re enjoying ReachMD…but how about a more personalized experience?
Javeed Siddiqui, MD, MPH
Understanding 2019 CDC Recommendations for Pneumococcal Disease in Adults Ages 65+
Javed Butler, MD, MPH, MBA
Robert J. Mentz, MD
Bill Colucci, MD
What Are the Risks and Outcomes Associated With Worsening Heart Failure Events?
How Do We Identify Patients With Chronic HFrEF Experiencing Worsening Heart Failure Events?
Which Signaling Pathways Are Disrupted During a Worsening Heart Failure Event?
Jennifer Caudle, DO
Victor F Tapson, MD
When Were Oral PPAs Considered for PAH Patients in Common Clinical Scenarios?
Steven Fein, MD
Clinical Trial Data Evaluating a Treatment for Deep Vein Thrombosis (DVT) and/or Pulmonary Embolism (PE) in Patients With Active Cancer
Ronald T. Uszenski, MD
Reducing the Risk of Stroke in Nonvalvular Atrial Fibrillation Patients With Obesity
Hiren M. Shah, MD
Stanley C. Thompson, MD
Managing VTE in the Hospital Setting
Lori Daniels, MD
All Elevations Are True Elevations with High-Sensitivity Troponin T
Ibrahim A Hashim, PhD
Elevating the Lab with High-Sensitivity Troponin T
Matthew C. Becker, MD
Arthur C. Lee, MD
Reducing the Risk of Cardiovascular Events in Patients With Chronic CAD/PAD
Frank LoVecchio, DO, MPH, FACEP
Treating Flu in High-Risk Populations
Casey Lafferty, DO
Trends, Treatments, & Tips for the Flu Season
Results of an Expert Delphi Consensus Survey on Clinical Scenarios Considered When Initiating Oral Prostacyclin Pathway Agents for Pulmonary Arterial Hypertension
Minimal Residual Disease & the Future of B-Cell ALL Treatment
You need to be logged in to save this episode to a playlist.
Press cancel to remain on ReachMD. Press the link below or the continue button to keep going.
Stay current with the best on medical education